ReviewAntioxidants (Basel, Switzerland)2021

Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy.

Zerrin Sezgin-Bayindir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.